JMJamie S. McConnell

Jamie S. McConnell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jamie S. McConnell has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The clinical relevance of sound changes produced during cementless hip arthroplasty

    by J. S. McConnell, P. R. J. Saunders, S. K. Young

    Aims: Cementless femoral stems must be correctly sized and well-seated to obtain satisfactory biological fixation. The change in sound that occurs during impaction of the femoral broach is said to indicate good fit, but this has not been widely studied. We set out to find whether the presence or absence of these sound changes could predict correct sizing. Patients and Methods: We recorded the sound generated during femoral broaching for 105 cementless total hip arthroplasties using the Corail stem. Four cases were excluded, leaving 101 recordings for analysis. There were 36 male patients and 65 female patients, with a mean age of 69.9 years (sd 12.3) and median body mass index (BMI) of 29 kg/m 2 (interquartile range (IQR) 26 to 32). The recordings were analyzed to identify the frequencies of the sounds produced during impaction of the femoral broach. Results: The emergence of a low-frequency band of sound in the 1 kHz range, during the final femoral broaching, was a strong predictor of a well-sized implant stem. The frequency was related to femoral length, supporting our hypothesis that the sound arose from the bone itself. Conclusion: The low-frequency sound generated during femoral broaching can be monitored spectrographically, its frequency can be predicted from femoral length, and it is a good predictor of appropriate stem sizing.


  • Open Access

    Blood Metal Ion Thresholds to Identify Patients with Metal-on-Metal Hip Implants at Risk of Adverse Reactions to Metal Debris

    by Gulraj S. Matharu, Fiona Berryman, Andrew Judge, Aleksi Reito, Jamie McConnell, Olli Lainiala, Stephen Young, Antti Eskelinen, Hemant G. Pandit, David W. Murray

    Background: The authors of recent studies have reported newly devised implant-specific blood metal ion thresholds to predict adverse reactions to metal debris (ARMD) in patients who have undergone unilateral or bilateral metal-on-metal (MoM) hip arthroplasty. These thresholds were most effective for identifying patients at low risk of ARMD. We investigated whether these newly devised blood metal ion thresholds could effectively identify patients at risk of ARMD after MoM hip arthroplasty in an external cohort of patients. Methods: We performed a validation study involving 803 MoM hip arthroplasties (323 unilateral Birmingham Hip Resurfacing [BHR], 93 bilateral BHR, and 294 unilateral Corail-Pinnacle implants) performed in 710 patients at 3 European centers. All patients underwent whole-blood metal ion sampling, and were divided into 2 groups: those with ARMD (leading to revision or identified on imaging; n = 75) and those without ARMD (n = 635). Previously devised implant-specific blood metal ion thresholds (2.15 μg/L of cobalt for unilateral BHR; 5.5 μg/L for the maximum of either cobalt or chromium for bilateral BHR; and 3.57 μg/L of cobalt for unilateral Corail-Pinnacle implants) were applied to the validation cohort, and receiver operating characteristic curve analysis was used to establish the discriminatory characteristics of each threshold. Results: The area under the curve, sensitivity, specificity, and positive and negative predictive values for the ability of each implant-specific threshold to distinguish between patients with and without ARMD were, respectively, 89.4% (95% confidence interval [CI] = 82.8% to 96.0%), 78.9%, 86.7%, 44.1%, and 96.9% for unilateral BHR; 89.2% (CI = 81.3% to 97.1%), 70.6%, 86.8%, 54.5%, and 93.0% for bilateral BHR; and 76.9% (CI = 63.9% to 90.0%), 65.0%, 85.4%, 24.5%, and 97.1% for unilateral Corail-Pinnacle implants. Using the implant-specific thresholds, we missed 20 patients with ARMD (2.8% of the patients in this series). We missed more patients with ARMD when we used the fixed thresholds proposed by regulatory authorities: 35 (4.9%) when we used the U.K. threshold of 7 μg/L for both cobalt and chromium (p = 0.0003), 21 (3.0%) when we used the U.S. threshold of 3 μg/L for both cobalt and chromium (p = 1.0), and 46 (6.5%) when we used the U.S. threshold of 10 μg/L for both cobalt and chromium (p < 0.0001). Conclusions: This external multicenter validation study confirmed that patients with blood metal ion levels below new implant-specific thresholds have a low risk of ARMD after MoM hip arthroplasty. Using these implant-specific thresholds, we missed fewer patients with ARMD compared with when the thresholds currently proposed by regulatory authorities were used. We therefore recommend using implant-specific blood metal ion thresholds when managing patients who have undergone MoM hip arthroplasty. Level of Evidence: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Knee Surgery: Soft Tissue (Volume 1)

    by Nicola Maffulli, François Kelbérine, Henrique Jones, Tiburtius V.S. Klos, Jamie S McConnell

  • Open Access

    Bilateral transient osteoporosis of the hip in a 20-year-old man

    by Jagwinder Dhaliwal, Jamie S McConnell, Tony Greer

    Transient osteoporosis is a rare musculoskeletal condition that has been reported in pregnant women and middle-aged men. We present a bilateral case in a young man. A 20-year-old man presented with spontaneous onset left hip pain. Investigations excluded other differential diagnoses such as infection or fracture. The pain resolved completely; 6 months later the patient presented with a similar episode of pain in the contralateral hip. This also resolved spontaneously. Doctors need to be aware of the possibility of spontaneous onset musculoskeletal pain due to transient osteoporosis occurring in young men. The typical presentation is of spontaneous onset progressive pain, often affecting the hip. Other pathology must be excluded. The investigation of choice is MRI, and the treatment is simple analgesia.


  • Scapulothoracic dissociation following blunt trauma

    by Ali Taufeeq, Jamie S McConnell

    Radiographs demonstrated a lateral third clavicle fracture and lateral deviation of the scapula (figure 1). The scapula usually articulates with ribs 2–7; …


  • Reducing blood loss in primary knee arthroplasty: A prospective randomised controlled trial of tranexamic acid and fibrin spray

    by Jamie S. McConnell, Sandeep Shewale, Niall A. Munro, Kalpesh Shah, Angela H. Deakin, Andrew W.G. Kinninmonth


  • Management of acute anterior shoulder dislocation

    by Benan Dala-Ali, Marta Penna, Jamie McConnell, Ivor Vanhegan, Carlos Cobiella

    Shoulder dislocation is the most common large joint dislocation in the body. Recent advances in radiological imaging and shoulder surgery have shown the potential dangers of traditional reduction techniques such as the Kocher's and the Hippocratic methods, which are still advocated by many textbooks. Many non-specialists continue to use these techniques, unaware of their potential risks. This article reviews the clinical and radiographic presentation of dislocation; some common reduction techniques; their risks and success rate; analgesia methods to facilitate the reduction; and postreduction management. Many textbooks advocate methods that have been superceded by safer alternatives. Trainees should learn better and safer relocation methods backed up by the current evidence available.


    • 1 February 2012
      • Vol. 78  (1) , 75-9

    Blood loss following total knee replacement is reduced when using computer-assisted versus standard methods.

    by Jamie McConnell, John Dillon, Andrew Kinninmonth, Martin Sarungi, Frederic Picard

    Perioperative blood loss was compared in 136 patients (2 groups of 68 patients) who underwent total knee arthroplasty (TKA). Blood loss was significantly lower when using a computer-navigated technique in comparison to a method employing intramedullary femoral rods. Total blood loss was calculated from body weight, height and haematocrit change, using a model that has been shown to reliably estimate true blood loss. Average total blood loss was 1362 ml in the standard TKA group, and 1137 ml in the computer navigated TKA group. This difference was statistically significant (p = 0.016). This study, as compared to previous papers assessing the effects of navigation, used a larger sample size and a more reliable method of assessing blood loss, which takes account of "hidden" losses, and confirms their findings.


  • Open Access

    Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray

    by Jamie S McConnell, Sandeep Shewale, Niall A Munro, Kalpesh Shah, Angela H Deakin, Andrew Wg Kinninmonth

    Previous studies have shown that either fibrin spray or tranexamic acid can reduce blood loss at total hip replacement, but the 2 treatments have not been directly compared. We therefore conducted a randomized, controlled trial. In this randomized controlled trial we compared the effect of tranexamic acid and fibrin spray on blood loss in cemented total hip arthroplasty. 66 patients were randomized to 1 of 3 parallel groups receiving (1) a 10 mg/kg bolus of tranexamic acid prior to surgery, (2) 10 mL of fibrin spray during surgery, or (3) neither. All participants except the surgeon were blinded as to treatment group until data analysis was complete. Blood loss was calculated from preoperative and postoperative hematocrit. Neither active treatment was found to be superior to the other in terms of overall blood loss. Losses were lower than those in the control group, when using either tranexamic acid (22% lower, p = 0.02) or fibrin spray (32% lower, p = 0.02). We found that the use of tranexamic acid at induction, or topical fibrin spray intraoperatively, reduced blood loss compared to the control group. Blood loss was similar in the fibrin spray group and in the tranexamic acid group. ClinicalTrials.gov identifier: NCT00378872. EudraCT identifier: 2006-001299-19. Regional Ethics Committee approval: 06/S0703/55, granted June 6, 2006.


  • Formularies should list animal derived excipients of drugs

    by Jamie S McConnell, Jyoti Josson

    Shiwani reminds us that patients are not always aware that surgical implants may originate from animal tissue.1 Doctors may also be unaware that they are prescribing …